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Abstract
Background
Schistosomiasis, one of the neglected tropical diseases (NTD) listed by the WHO, is an
acute and chronic parasitic disease caused by blood flukes (trematode worms) of the genus
Schistosoma. Complications of long-term infestation include liver cirrhosis, bladder tumors
and kidney failure. The objective of this study was to carry out a clinical and epidemiological
characterization of a schistosomiasis-diagnosed immigrant population with long-term resi-
dencein the EU as well as to evaluate the diagnostic methods available to date.
Methods and results
A total of 61 individuals with Schistosoma infection who received medical attention between
June 2002 and June 2016 at the North Metropolitan International Health Unit in Barcelona
(Catalonia, Spain), were included in the study. All patients were sub-Saharan African immi-
grants. The majority were male (91.8%) with a median age of 34 years. Symptoms attribut-
able to infection such as haematuria, abdominal pain and dysuria were recorded in up to
90% of patients. The percentage of eosinophils decreased amongst older patients (p =
0.002) and those with symptoms associated with urinary tract infections (p = 0.017). Serol-
ogy was used for diagnosis in 80.3% of the cases, with microscopic examination showing
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the remaining 9.8% positive for parasite eggs. Direct microbiological diagnosis was more
useful in patients with less than 5 years of residence in the EU (p = 0.05). Chronic complica-
tions were present in 22 (36%) of the patients, with renal failure affecting 20 (33%). Of these
20, 6(10%) developed terminal renal failure and required hemodialysis, while 3 (5%)
received a renal transplantation.
Conclusion
Morbidity associated with chronic long-term schistosomiasis is frequent among African
immigrants in non-endemic countries. Better diagnostic tools and appropriate early treat-
ment would prevent the development of visceral damage. Thorough screening in selected
patients would also be useful to avoid chronic complications.
Introduction
Schistosomiasis is an endemic helminthiasis caused by trematodes of the genus Schistosoma.
The main disease-causing species are Schistosoma mansoni (Africa and South America), S. hae-
matobium (Africa and the Middle East), and S. Japonicum (East Asia). At the present time more
than 74 countries worldwide are considered endemic for the disease and around 200 million
individuals are infected, especially in sub-Saharan Africa. Beyond its public health implica-
tions, the infection is regarded as one of the tropical parasitic diseases with greatest socioeco-
nomic impact [1].
Chronic schistosomal disease mainly affects individuals with long-standing infections.
Immunopathological reactions to schistosome eggs trapped in the tissues lead to inflammatory
and obstructive disease in either the urinary system (S. haematobium) or the digestive tract
such as with hepatosplenic inflammation and even liver fibrosis (S. mansoni, S. japonicum) [2].
Despite the availability of simple and effective diagnostic tests and treatments, chronic disease
is rarely symptomatic and can often lead to tissue damage resulting in severe end-stage renal
failure, cirrhosis, pulmonary hypertension or, more rarely, neurological complications.
The continuous flow of immigrants from schistosomiasis-endemic countries to the Euro-
pean Union has inevitably included a certain number of chronically infected individuals. The
usual first-step diagnostic test is based on the microscopic identification of Schistosoma eggs
either in feces or urine, a very useful method when the parasite load is high [3]. In non-
endemic countries, nevertheless, the positive predictive value of such direct techniques
decreases noticeably owing to the low parasite load of long-term- infections and the lack of
microscopy-experienced staff. To date, the absence of a true gold standard for quantitative cor-
relations to actual worm burden remains a significant challenge [4].
As a result, diagnosis among immigrant populations is usually delayed and performed only
when complications are already established, thus complicating the management and prognosis
of the disease as well as the effectiveness of treatment. Thus active screening of the population
considered at risk and the application of adequate diagnostic methods are the key to improving
the prognosis of these long-term infected patients. Moreover, immediate and pro-active atten-
tion to cases could lead to substantial economic savings by avoiding organ end-stage diseases,
transplants and other costly sequelae.
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Materials and methods
Study population
From June 2002 to June 2016, information about all individuals diagnosed with a Schistosoma
infection at the North Metropolitan International Health Unit (Barcelona, Catalonia, Spain)
was recorded and included in the study. This center serves a population of approximately
400,000, of which about 12,900 (21%) are immigrants from high-endemic African countries. It
belongs to the Institut Català de la Salut, a public health service, so medical visits are easily
accessible and free of charge. Most of the patients were referred by family physicians, while
others came from various hospital services. Schistosomiasis was diagnosed through a) a posi-
tive identification of parasite eggs in stool or urine samples, b) the presence of specific antibod-
ies detected in blood or c), exceptionally, high clinical and/or radiological suspicion.
From May 2015, every patient complying with the following two major criteria and two or
more minor criteria was systematically tested for schistosomiasis. The major criteria were a)
long-term or frequent presence in an endemic country because of either or frequent travel,
and b) prior history of freshwater river, lake or pond exposure. Minor criteria were any signs
or symptoms suggestive of Schistosoma infection such as eosinophilia, haematuria, dysuria,
recurrence urinary tract infections, renal failure, nephritic colic, abdominal pain, rectal bleed-
ing, chronic hepatopathy or transaminitis of unknown origin, sterility, ictus/myelitis, urinary
tract involvement, or liver involvement. The pathological antecedents and blood test data of
the patients were collected in the shared intranet medical history (primary care, tertiary-level
hospital and laboratory) of the Institut Català de la Salut. Recurrent urinary tract infections
were defined as>2 urinary tract infections (urinalysis either by microscopy or by dipstick
and/or urine culture with susceptibility data) and were recorded in the clinical history. Renal
insufficiency were defined as decreased estimated glomerular filtration rate (< 60ml/min/
1.73m2) or elevated blood creatinine (> 1.3mg/ml). Sterility was defined as inability of a couple
to conceive after 12 months of regular intercourse without use of contraception.
Patients with positive serology but reporting previous treatment with praziquantel were
excluded from the study.
Data was collected and analyzed in an anonymous way always respecting the usual confi-
dentiality requirements. Written informed consent was obtained from all patients or their
guardians. This study was approved by the Clinical Research Ethics Committee at our institu-
tion (“Comite´ E´tico de Investigacio´n Clı´nica”, CEIC).
Diagnostic tests and management
Between June 2002 and April 2009, the only available diagnostic tool was a direct microscopy
identification for parasite eggs in feces (three fixed stool samples in formalin) or urine col-
lected in 24 hours). All samples were sent to the Microbiology Department where stool sam-
ples were processed by formalin-ethyl acetate sedimentation concentration while urine
samples were centrifuged at 400 × g. Wet mount was performed to detect Schistosoma eggs,
especially S. haematobium in urine and S. mansoni in stool samples.
From May 2009, serum samples were sent to the Centro Nacional de Microbiologı´a (CNM)
a center belonging to the Instituto de Salud Carlos III in Majadahonda, Madrid, Spain, to be
tested for Schistosoma by an ELISA Novalisa™ IgG (Novatec Inmunodiagnostica GmbH, Ger-
many) immunoassay [5].
An abdominal and urinary tract ultrasonography was performed on all those patients who
showed positive for schistosomiasis. Patients with confirmed infection were treated with prazi-
quantel 60mg/kg orally given in two divided doses for one day. A repeat course of treatment
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was given two weeks after the initial one. A prior treatment with steroids was given when neu-
rological complications were present.
The patients were followed-up with new samples of feces/urine, a complete blood count,
blood chemistry and abdominal ultrasonography, after six months of treatment.
Statistical analysis
The variables assessed were age, sex, country of origin, length of residence in the EU (years),
eosinophil count (with eosinophilia if> 500 cells/μL or absolute count> 8%), known anteced-
ent of schistosomiasis (yes/no), presence of haematuria during childhood (yes/no), presence of
symptoms (yes/no), type of symptoms, complications, diagnostic test (direct microscopy,
serology or imaging test), abdominal ultrasonography (normal, abnormal), identified Schisto-
soma species, correct treatment with praziquantel (yes/no), favorable clinical course after treat-
ment (yes/no), normal eosinophil count after treatment (yes/no) and family checking (yes/
no).
Categorical variables and continuous data were reported as percentages and
mean ± standard deviation (SD), respectively. To detect significant differences between
groups, we used the chi-squared or Fisher’s exact test for categorical variables, and the Student
t test or Mann–Whitney U test for continuous variables, when appropriate. Statistical signifi-
cance was established at α = 0.05. All reported p values are two-tailed. Statistical Package for
the Social Science for Windows (SPSS, version 20; Chicago, Illinois, USA) was used for the sta-
tistical analysis.
Results
During the study period, 61 individuals were diagnosed with Schistosoma spp. infection. Their
socio-demographic and clinical characterization is displayed in “Tables 1 and 2”. From the
beginning of the screening period, 34 individuals complied with the screening criteria and, of
them, 29 (85%) had a positive serology for Schistosoma spp. Urogenital schistosomiasis was the
main type of affliction, with 45(73.8%) patients reporting having had macrohaematuria epi-
sodes during their childhood. Serious complications were recorded in 22 (36%) patients, 20
chronic renal failure (32.8%) being the most severe complication followed by 2 patients with
ischemic cerebrovascular stroke (3.3%). A total of 6 patients with renal failure required hemo-
dialysis, and 3 underwent kidney transplantation (two patients of these requiring two succes-
sive transplantations). The parasitic diagnosis in all cases was subsequent to transplantation.
Serology was the most sensitive diagnostic test. A list of the diagnostic tools used is shown
in “Table 3”.
Although family physicians had suspected the presence of parasitic infection and initiated
the diagnostic process in 23% of cases, diagnosis was achieved in none of them. A total of 46
(75%) patients successfully completed the treatment with praziquantel, the majority of failures
to complete being due to absence in follow-up visits. Hepatitis B coninfection with superficial
antigen Hepatitis B (HBsAg+) was identified in 12 (19.7%).
According to bivariate analysis, a negative relationship exists between both the eosinophil
counts and eosinophil percentages and the older patients (p = 0.002 “Fig 1”, p = 0.003 and
respectively). In addition, older patients showed higher creatinine levels and lower levels of
eosinophilia (p = 0.029). They were also more symptomatic, had more urine infections (both
p = 0,017) and tended to have more renal colic (p = 0.069). Patients with HBV coinfection had
higher but not significantly elevated transaminase serum levels.
Direct microscopic examination for ova in urine or feces was a more useful method in
patients who had been residing in the EU for less than 5 years, while serology testing was a
Chronic schistosomiasis from a non-endemic country
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Table 1. Socio-demographic and clinical characteristics of Schistosoma spp cases (n = 61).
Variable N(%)
Mean age, years (range) 34 (31–42)
Sex
Male 56 (91.8)
Female 5 (8.2)
Country origin
Senegal 23 (37.7)
Mali 14 (23)
Gambia 11 (18)
Nigeria 4 (6.6)
Other 9 (14.7)
Mean Length of residence, years (range) 9 (7-11y)
Eosinophil count
Mean(range) 580 (200–800)
Median 10 (4–13)
According count 31 (50.8)
According percentage 34 (55.7)
Previous Schistosoma spp. infection.
No 49 (80.3)
Yes 3 (4.9)
Childhood haematuria
Yes 45 (73.8)
Symptoms
Presence 55 (90)
Absence 6 (10)
Diagnostic test
Microscopy 6 (9.8)
Serology 49 (80.3)
Clinical findings 2 (3.3)
Clinical and radiological findingsa 4 (6.5)
Renal abdominal Ultrasound (n = 37)
Abnormal 23 (62.1)
Urinary tract involvement 19 (31.1)
Liver involvement 6 (12)
Schistosoma type
Urogenital 34 (55.7)
Abdominal 8 (13.1)
Unknown 19 (31.1)
Praziquantel treatment
Yes 46 (75)
Improvement transaminase serum levels after treatment (n = 14) 10 (71)
Improvement eoshinophil count after treatment (n = 24) 21 (87.5)
Primary Care Phisician (n = 57) 14 (23)
a urinary tract involvement.
https://doi.org/10.1371/journal.pone.0185245.t001
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clearly more effective method among patients who had resided 5 years or more in the EU
(p = 0.05).
Regarding area of origin, Western Africa (especially Mali and Senegal) was the main source
of infection, as shown in “Table 4”. In fact, the study population included no patients native to
other endemic areas such as Brazil, Yemen or Southeast Asia. The eosinophil count was signifi-
cantly higher in patients from Gambia compared with those from Senegal (90.9% vs 36.4%,
p = 0.003). Abnormal ultrasound images were more frequently found in patients from Nigeria
than among patients from Senegal, Mali or Gambia (p = 0.005). Elevation of transaminase
serum levels was higher in patients from Nigeria but this difference was not statistically
significant.
Discussion
The continuous flow of immigrants from endemic countries mainly in sub-Saharan Africa has
conditioned the emergence of chronic parasitosis in the EU. Nevertheless, due to low symp-
tomatology, diagnosis of these imported infections is often delayed and follow-up is often
difficult owing to the frequency of changes in job and/or residence among immigrants. Fre-
quently, diagnosis does not occur until disease has reached advanced stages with chronic liver
disease or renal failure irremediably established. Other authors have already called attention to
the presence of long-lasting undiagnosed schistosomiasis cases among immigrant populations
established in Europe, with Senegal, the Gambia, Mali and Nigeria being the most common
countries of origin [6–8]. Despite such words of warning, however, literature dealing with
Table 3. Diagnostic test.
Test N (%)
Dipstick urine test (49) 23 (46.9)
Eggs in urine (52) 4 (7.7)
Eggs in stool (41) 2 (4.8)
ELISA serology 49 (80.3)
Clinical suspicion 2 (3.3)
Clinical + radiological suspiciona 4 (6.5)
a urinary tract involvement.
https://doi.org/10.1371/journal.pone.0185245.t003
Table 2. Type of symptoms and complications.
Variable (n) N (%)
Dysuria (59) 30 (49.2)
Haematuria (60) 44 (72.1)
Recurrent urinary tract infections (58) 23 (37.7)
Renal colic (58) 8 (13.1)
Abdominal pain (58) 31 (50.8)
Diarrhea (59) 5 (8.2)
Sterility (26) 5 (8.2)
Renal insufficiency (59) 20 (32.8)
Median creatinine level (mg/dl) 1.4 (1.39–2.06)
Hemodialysis (60) 6 (9.8)
Renal transplant (60) 3 (4.9)
Ischemic cerebrovascular stroke (60) 2 (3.3)
https://doi.org/10.1371/journal.pone.0185245.t002
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chronic schistosomiasis in the EU is scarce, with most studies focusing on cases involving
newly acquired schistosomiasis imported by travelers rather than long-term infection [9–11].
In France, a European country with a high percentage of sub-Saharan immigrants, a systematic
survey of intestinal parasite infections in an immigrant population found Schistosoma haema-
tobium to be the most dangerous parasitic disease [12].
Fig 1. Age and eosinophil count at the time of diagnosis of Schistosoma spp (p = 0.002).
https://doi.org/10.1371/journal.pone.0185245.g001
Table 4. Comparative analysis of variables according to patients’ country of origin.
Gambia N = 11 Mali N = 14 Senegal N = 23 Nigeria N = 4 Other N = 9N pa
Eosinophilia 9 (81.8%) 9 (64.2%) 11 (47.8%) 2 (50%) 6 (66.7%) 0.44
Transaminitis 5 (45.5%) 3 (21.4%) 7 (30.4%) 4 (100%) 3 (33.3%) 0.09
Renal colic 0 (0%) 3 (21.4%) 5 (21.7%) 0 (0%) 0 (0%) 0.06
RecurrenceUTI 1 (9%) 7 (50%) 11 (47.8%) 2 (50%) 2 (22.2%) 0.08
Dysuria 2 (18.1%) 7 (50%) 16 (69.5%) 2 (50%) 4 (44.4%) 0.09
Haematuria 6 (54.5%) 12 (85.7%) 17 (73.9%) 3 (75%) 6 (66.6%) 0.23
Abnormal renal US 9 (81.8%) 5 (35.7%) 11 (47.8%) 4 (100%) 9 (100%) 0.0050
S. haematobium (n = 34) 6 (75%) 9 (100%) 14 (82.4%) 2 (50%) 3 (75%)
S.mansoni (n = 38) 2 (25%) 0 (0%) 3 (17.6%) 2 (50%) 3 (75%)
Note:
a Statistical significance was set at α = 0.05;
UTI: urinary tract infections; US: ultrasound.
https://doi.org/10.1371/journal.pone.0185245.t004
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It is essential for local medical services to be able to detect signs and symptoms of schistoso-
miasis in such patient populations who are living far outside endemic areas. The symptoms of
chronic infection often have an insidious onset and as a result, if there is no clinical suspicion,
diagnosis can be late and performed when complications are already present [13].
In our study, up to 90% of the patients had symptoms attributable to the infection.
Although family physicians started the diagnostic process in 23% of the cases reported, in
none of these, schistosomiasis was finally diagnosed in the primary care centers. The only diag-
nostic test available to these primary care doctors was direct microscopy examination of urine
and/or stools, which is not particularly sensitive in patients with chronic infection and low par-
asitic load. This technique lacks sensitivity and does not take into account day-to-day variation
in egg output [14]. In other words, primary care services tend to lack proper diagnostic tools, a
situation that precludes the possible implementation of any screening program. In the present
study, the diagnosis was always carried out by a specialized international health unit and was
based first on a high clinical suspicion and second on a proactive search for symptoms using
indirect methods, mainly serology. Had the primary care services been endowed with a proper
serologic test, more patients might have been identified earlier. With regard to the situation in
Catalonia, the geographic area covered by the present study, recommendations along these
lines had already been made by the Catalan Society of Primary Health, which called for the
availability of diagnostic tools to enable the direct identification of schistosome eggs [15]. This
study points to two other factors which can be used to identify risk and thus improve the pre-
dictive value of serology, namely personal antecedents of macrohaematuria (which affected
74% of the population reported here) and dipstick test results positive for blood (47%) [16,17].
Also, echographic exploration is able to show organ abnormalities in a substantial proportion
of patients, and we recommend that this innocuous exploration should be included in the
basic diagnostic process.
Within a period of 14 years, 61 cases of schistosomiasis were identified. From 2002 to 2008
the diagnoses were based on direct parasitological testing and/or clinical suspicion. Starting in
2009, the introduction of serological tests resulted in an increase in the number of diagnosed
cases. Moreover, after 2015 patients with risk criteria were screened for infection. The combi-
nation of serology testing and the record of some simple data such as country of origin, haema-
turia in childhood or eosonophil count, tripled the number of diagnoses (see “Fig 2”).
Our results compel us to question the true degree of underdiagnosis in our country. Quite
possibly the disease is far more common than presumed. However, probably because of its
insidious clinical presentation, the low degree of knowledge about the disease and the absence
of accessible tests, family practitioners have few tools to diagnose schistosomiasis.
Chronic and irreversible complications, especially renal failure, were present in a high per-
centage of patients included in this study. We emphasize that in the 6 patients with terminal
renal failure the diagnosis of schistosomiasis was made when the structural damage was
already irreversible. In this phase of infection we often could not discern the species of Schisto-
soma involved since renal failure is a complication that can be due not only of S. haematobium
but also S.mansoni, secondary to glomerular damage [18]. The importance of starting treat-
ment as early as possible must be highlighted, particularly in those patients awaiting renal
transplantation, given the possibility of recrudescence of the disease in the transplanted kidney
[19, 20]. It would be reasonable to implement Schistosoma serology screening for all those
patients coming from endemic countries and suffering renal insufficiency of unknown origin.
The low number of Schistosoma infections identified among women (only 5 which repre-
sent a 8.2%) is striking considering that prevalences in endemic countries do not show signifi-
cant differences by gender [16, 21, 22]. The reason is not known but it may be related to the
higher proportion of male sub-Saharan immigrants compared with women. Other possible
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factors might be that the presence of urinary symptoms are more common and more nonspe-
cific in women than in men, or the confounding role of gynecological symptoms [23,24].
Co-infection with HBV (19.7% of patients) is a demonstrable risk factor for developing
liver disease earlier and to more serious degree [25]. Therefore, screening for the hepatitis B
virus (and also hepatitis C virus) should be integrated into the management of these patients.
Regarding the economic aspects of the disease, 9 out of 22 patients diagnosed with chronic
organ complications generated a direct health expenditure of €369,230/year; 6 of them under-
went hemodialysis (€23,620/person/year) with kidney transplantations in 3 (€17,158/trans-
plant), not to mention the costs associated with medication and hospital admissions [26]. In
contrast, the pharmacological treatment of the 22 patients treated with praziquantel amounted
to €2,200. An earlier diagnosis would surely have avoided the high cost of treating complica-
tions. The difficulty of diagnosis in the chronic phase of the infection points to the urgency of
upgrading diagnostic methods by means of specialized devices. Serology, the standard screen-
ing method, has a sensitivity of over 90% for travelers and slightly less for people originally
from endemic countries [27]. Antibody-based assays are quite sensitive but cannot distinguish
history of exposure from active infections, and the results can also reflect cross-reaction with
other platyhelminths. Therefore, among individuals native to Schistosoma-endemic areas the
implementation of antigenic or molecular techniques should be considered [28]. Recent
Fig 2. Cases of Schistosomiasis according to year of diagnosis.
https://doi.org/10.1371/journal.pone.0185245.g002
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studies advocate the use of these diagnostic methods in patients with presumed exposure such
as long-standing immigrants [29–33]. Such techniques would make it possible to differentiate
between active disease from chronic or treated schistosomiasis. Thus far, the outcome of treat-
ment has been based on indirect markers such as normalization of eosinophilia and liver
enzymes which are highly unreliable.
The present study assesses African immigrant community long established in the EU. The
number of similar articles is very limited, and its singularity could be considered its main
strength. When analyzing sub-categories, however, the number of patients is actually quite
small; more and larger samples are needed in order to be able to draw categorical conclusions.
The Mediterranean area is a former habitat of Bulinus snails and, furthermore, climate
warming could spread the conditions that favor local genitourinary schistosomiasis transmis-
sion to southern Europe. In 2013, an unexpected outbreak of urogenital schistosomiasis
occurred in Corsica, France, with more than 120 local people or tourists infected. Molecular
sequence data analysis showed that the Corsican schistosomes were closely related to those
from Senegal, in West Africa. The emergence of urinary schistosomiasis in Corsica suggests
that schistosomiasis could be a cause for concern in a Mediterranean Bulinus-colonized
Europe [34]. Whether the source of the outbreak in Corsica was sub-clinical infected immi-
grants or not, remains unclear; nevertheless, a more comprehensive EU-wide approach,
including screening of high-probability communities, seems advisable.
Several factors play a role in the reality of schistosomiasis in non-endemic countries pro-
ducing a delay in the diagnose, specially the high percentage of complications,the low clinical
suspicion rate and the difficulty of diagnosis. The present study highlights the need to improve
management and earlier detection of the disease through the implementation of screening
protocols among populations at risk.
In short, long-term schistosomiasis remains a problem even in an area previously identified
as of high prevalence among immigrants. We therefore recommend the introduction of a
screening program based on first a questionnaire about symptoms and signs of active infection
and then serological testing.
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